A well-written briefing paper from the Biopharmaceutical Think Tank discussion at the 2019 IFC Global Private Health Care by Chrissy Bishop with guidance from Tim Gamble, both of The Economist Intelligence Unit (EIU) Healthcare team.
Paper has discussed 3 key areas for development in the biopharmaceutical industry that may assist with regulatory harmonization and improving the sustainability of pricing of biopharmaceutical drugs in emerging markets.

Available on the link below:

Improving Access and Affordability for Biopharmaceuticals in Emerging Markets